Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 23, 2017

View Archived Issues

Atara Biotherapeutics starts phase I study of allogeneic ATA-188 in multiple sclerosis

[68Ga]NODAGA-exendin-4 used to image beta cells after Roux-en-Y gastric bypass

Novel orally bioavailable BAX activator shows promising antitumor activity in leukemia xenografts

Novel glucosylceramidase activators presented by Lysosomal Therapeutics

Osimertinib-savolitinib combination shows promise in EGFR-mutant NSCLC

Researchers describe a novel athyroid mouse model

FDA approves Shingrix

Spero Therapeutics commences clinical testing of SPR-994

FDA approves Simponi Aria for psoriatic arthritis and ankylosing spondylitis

FDA grants new breakthrough therapy designation to Tafinlar + Mekinist in melanoma

VBL Therapeutics' VB-111 granted orphan medicinal product status in E.U.

FDA grants orphan drug designation to Cx-601 for fistulizing Crohn's disease

Activity seen with etirinotecan pegol in phase II small-cell lung cancer trial

New susceptibility genes revealed for Kawasaki disease

FDA issues complete response letter for Xyosted

FDA approves Bydureon BCise

Ergomed reports phase II topline results for first-in-class hemostat PeproStat

Japanese NDA filing for Lynparza for germline BRCA-mutated, HER2-negative metastatic breast cancer

Population Council initiates phase I study of griffithsin gel for HIV prevention

Immunomedics initiates phase III study of sacituzumab govitecan for triple-negative breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...